COVID-19
Nuclein Obtains FDA Clearance, CLIA Waiver for Rapid COVID/Flu Molecular Test System
The firm plans to expand the test menu for its DASH system to include additional respiratory infections and sexually transmitted infections, as well as other assays.
In the wake of suspending guidance to review the business in the first quarter of the year, QuidelOrtho has restructured and resumed offering a financial outlook.
FDA Clears Qiagen QiaStat-Dx Respiratory Mini Panel
The panel detects influenza A and B, respiratory syncytial virus, SARS-CoV-2, and human rhinovirus.
BARDA Awards Revvity $9.2M, Partners With Sherlock Biosciences for COVID/Flu Home Tests
Both firms will develop rapid, home-use diagnostic tests to simultaneously detect SARS-CoV-2, influenza A, and influenza B.
SARS-CoV-2 Genetic Study of Environmental Samples Links Pandemic to Wuhan Market, Wild Animal Trade
A series of genetic and geospatial analyses of environmental samples collected at the Huanan market in Wuhan in 2020 linked early SARS-CoV-2 spread to the wild animal trade.
May 23, 2024
Cue Health Shutting Down Operations
May 13, 2024
FDA Warns Against Use of Cue Health COVID-19 Tests
Apr 12, 2024